RET and anemia (phenotype): In 2021, the Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggested updating anemia guidelines to use the RET-He biomarker in the clinical practice to assess marrow efficiency of erythropoiesis at an early stage.16